Retatrutide is injected subcutaneously once weekly, and using the same location repeatedly can cause tissue irritation, lumps, and potentially affect absorption
However, Zepbound's OSA indication is differentsome MA plans began covering Zepbound for sleep apnea in 2025-2026, as OSA is not classified as a "weight loss" indication
Wharton, S., Astrup, A., & Adam, T
If you are planning to conceive: If you become pregnant while using Ozempic, contact your doctor immediately
Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
While PAP may be beneficial in a subset of patients with OSA, emerging preclinical and clinical data suggest it may potentially cause harm in others [27], particularly at higher pressures [28], though this requires rigorous validation in future studies